Phio Pharmaceuticals Corp. Files 8-K with Material Agreements
Ticker: PHIO · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1533040
| Field | Detail |
|---|---|
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-action
TL;DR
Phio Pharma dropped an 8-K detailing material agreements and equity sales. Check it out.
AI Summary
Phio Pharmaceuticals Corp. entered into a Material Definitive Agreement on July 25, 2025. The company also reported on unregistered sales of equity securities and other events. This filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate actions and financial disclosures by Phio Pharmaceuticals Corp., which could impact investors' understanding of the company's current status and future prospects.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can lead to significant stock price movements, requiring careful investor attention.
Key Players & Entities
- Phio Pharmaceuticals Corp. (company) — Registrant
- July 25, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-36304 (identifier) — Commission File Number
- 45-3215903 (identifier) — I.R.S. Employer Identification No.
- 411 Swedeland Road, Suite 23-1080 (address) — Principal executive offices
- King of Prussia, PA 19406 (address) — Principal executive offices
- RXi Pharmaceuticals Corp (company) — Former company name
- 20111019 (date) — Date of former company name change
FAQ
What specific Material Definitive Agreement did Phio Pharmaceuticals Corp. enter into?
The filing states that Phio Pharmaceuticals Corp. entered into a Material Definitive Agreement, but the specific details of this agreement are not provided in the provided text excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 25, 2025.
What is Phio Pharmaceuticals Corp.'s state of incorporation?
Phio Pharmaceuticals Corp. is incorporated in Delaware.
What is the Commission File Number for Phio Pharmaceuticals Corp.?
The Commission File Number for Phio Pharmaceuticals Corp. is 001-36304.
What was the former name of Phio Pharmaceuticals Corp. and when did the name change occur?
The former name of Phio Pharmaceuticals Corp. was RXi Pharmaceuticals Corp, and the date of the name change was October 19, 2011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding Phio Pharmaceuticals Corp. (PHIO).